Brun Scott C.
Transaction: 06/09/2026
BUY
Change
+22,000
Price
$3.22
Filing
06/10/2026
Type
BUY
Cabaletta Bio, Inc.
CABA • Biotechnology
$3.42
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$517.07M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.24Healthy liquidity · 2.77Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:12 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.42
Change0.00%
Shares Out151.16M
Market Cap$517.07M
Enterprise Value$291.97M
52W Range1.40 - 4.23
Beta3.25
P/E-2.85
P/B2.46
P/FCF-3.35
EV/EBITDA-1.65
EV/FCF-1.89
Price$3.42
Change0.00%
Shares Out151.16M
Market Cap$517.07M
Enterprise Value$291.97M
52W Range1.40 - 4.23
Beta3.25
P/E-2.85
P/B2.46
P/FCF-3.35
EV/EBITDA-1.65
EV/FCF-1.89
Earnings Yield-35.07%
FCF Yield-29.82%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.24
Current Ratio2.77
Quick Ratio2.77
Target$16.33
Target Upside377.39%
Target Median$14.00
Target Range3.00 - 32.00
Volume3.05M
Avg Volume4.18M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Manageable debt level · 0.24Healthy liquidity · 2.77Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 12 analyst votes · 2026-09-04
92/100
Bullish
Bullish
10
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$3.00
Mean
$16.33
Median
$14.00
High
$32.00
Insider Transactions
Recent executive and insider activity
Bollard Catherine
Transaction: 06/09/2026
BUY
Change
+22,000
Price
$3.22
Filing
06/10/2026
Type
BUY
HENRIQUES RICHARD C JR
Transaction: 06/09/2026
BUY
Change
+22,000
Price
$3.22
Filing
06/10/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Brun Scott C. | BUY | +22,000 | $3.22 | 06/09/2026 | 06/10/2026 |
| Bollard Catherine | BUY | +22,000 | $3.22 | 06/09/2026 | 06/10/2026 |
| HENRIQUES RICHARD C JR | BUY | +22,000 | $3.22 | 06/09/2026 | 06/10/2026 |
| Simon Mark | BUY | +22,000 | $3.22 | 06/09/2026 | 06/10/2026 |
| Tomasello Shawn | BUY | +22,000 | $3.22 | 06/09/2026 | 06/10/2026 |
| Marda Anup | BUY | +225,000 | $3.30 | 03/02/2026 | 03/02/2026 |
| Nichtberger Steven | BUY | +674,000 | $3.30 | 03/02/2026 | 03/02/2026 |
| Chang David J. | BUY | +225,000 | $3.30 | 03/02/2026 | 03/02/2026 |
| Binder Gwendolyn | BUY | +225,000 | $3.30 | 03/02/2026 | 03/02/2026 |
| Gerard Michael | BUY | +175,000 | $3.30 | 03/02/2026 | 03/02/2026 |
| Das Arun | BUY | +175,000 | $3.30 | 03/02/2026 | 03/02/2026 |
| Gerard Michael | BUY | +6,600 | $2.27 | 01/21/2026 | 01/21/2026 |
| Simon Mark | BUY | +11,061 | $2.28 | 01/21/2026 | 01/21/2026 |
| Nichtberger Steven | BUY | +45,000 | $2.24 | 01/21/2026 | 01/21/2026 |
| Bollard Catherine | BUY | +4,405 | $2.27 | 01/21/2026 | 01/21/2026 |
| Gavel Steve | BUY | +22,170 | $2.27 | 01/21/2026 | 01/21/2026 |
| Tomasello Shawn | BUY | +22,725 | $2.21 | 01/21/2026 | 01/21/2026 |
| Binder Gwendolyn | BUY | +11,312 | $2.19 | 01/21/2026 | 01/21/2026 |
| Chang David J. | BUY | +8,800 | $2.26 | 01/21/2026 | 01/21/2026 |
| Gavel Steve | OTHER | 0 | Not reported | 10/13/2025 | 10/15/2025 |